| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc03c63e6997a08c8b9761b5cfd6668c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2000-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa299286ecad629256da17ea03725b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4633caf0aa929c6651cec697f6d5c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45fc0a496ceb6db57c33115e93247747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7352a9b17a81a75de296b9aafd181e3 |
| publicationDate |
2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-513189-A |
| titleOfInvention |
Diagnosis of a personÆs risk for developing atherosclerosis or diabetic retinopathy |
| abstract |
Methods for diagnosing a person's susceptibility for having an increased risk for the development of atherosclerosis and a diabetic person's susceptibility for having an increased risk for the development of diabetic retinopathy and treating persons diagnosed for having increased risk for the development of these diseases, in order to prevent the development of these diseases are disclosed. The method for diagnosing an individual's susceptibility for having a risk for the development of atherosclerosis, comprising determining whether the individual subject has a polymorphism in the signal peptide part of the human preproNPY, the polymorphism comprising the substitution of the position 7 leucine for proline in the signal peptide part of the preproNPY, and the polymorphism being indicative of an increased risk for the development of atherosclerosis. Methods to investigate or screen pharmaceuticals or genetic aims useful in the treatment of these diseases, by using an animal model including a transgenic animal are also disclosed. |
| priorityDate |
1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |